WHO will decide on its hyrdroxychloroquine trial suspension in 24 hours

© Reuters. Coronavirus disease (COVID-19) outbreak in Liege

(Reuters) – The World Health Organization (WHO) should have enough information in 24 hours to decide whether to continue suspending its trials of hyrdroxychloroquine for use against the new coronavirus, its chief scientist Soumya Swaminathan said on Monday.

U.S. President Donald Trump has been one of those promoting the anti-malaria drug to help combat the COVID-19 disease, despite medical warnings about associated risks.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


READ  Trump's tweets against liberal congresswomen called racist


Please enter your comment!
Please enter your name here